Vimta Labs Ltd
NSE: VIMTALABS BSE: 524394
Vimta Labs Ltd (VIMTALABS) is a Diversified company listed on NSE: VIMTALABS | BSE: 524394. With a market cap of ₹1,990 Cr and ROCE of 25.2%, ROE of 18.8%, it operates in the Indian Diversified sector.
₹446
52W: ₹376 — ₹903
PE 25.3 · Book ₹102 · +337% vs bookMarket Cap₹1,990 Cr
Stock P/E25.3Price to Earnings
ROCE25.2%Return on Capital
ROE18.8%Return on Equity
Div. Yield0.44%Face Value ₹2
Strengths
- +Company has reduced debt.
- +Company is almost debt free.
- +Company has delivered good profit growth of 29.9% CAGR over last 5 years
Shareholding Pattern
Promoters35.85%
FIIs4.89%
DIIs0.13%
Public59.12%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 36.89% | 36.89% | 36.76%▼0.1 | 36.7%▼0.1 | 36.67%▼0.0 | 35.99%▼0.7 | 35.89%▼0.1 | 35.85%▼0.0 |
| FIIs | 5.16% | 3.31%▼1.9 | 3.81%▲0.5 | 3.66%▼0.1 | 3.49%▼0.2 | 4.33%▲0.8 | 4.59%▲0.3 | 4.89%▲0.3 |
| DIIs | 1.49% | 0%▼1.5 | 1.15%▲1.1 | 1.43%▲0.3 | 1.42%▼0.0 | 0.87%▼0.5 | 0.11%▼0.8 | 0.13%▲0.0 |
| Public | 56.45% | 59.8%▲3.3 | 58.28%▼1.5 | 58.2%▼0.1 | 58.42%▲0.2 | 58.8%▲0.4 | 59.4%▲0.6 | 59.12%▼0.3 |
Financial Statements
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 73 | 73 | 75 | 85 | 90 | 94 | 98 | 102 | 99 | 109 |
| Expenses | 50 | 47 | 49 | 55 | 57 | 61 | 64 | 68 | 64 | 70 |
| Operating Profit | 23 | 26 | 26 | 30 | 33 | 33 | 34 | 34 | 34 | 39 |
| OPM % | 31% | 36% | 35% | 35% | 37% | 35% | 35% | 34% | 35% | 36% |
| Net Profit | 9 | 12 | 12 | 15 | 22 | 18 | 19 | 20 | 18 | 21 |
| EPS ₹ | 2.14 | 2.79 | 2.77 | 3.44 | 4.84 | 4.12 | 4.24 | 4.47 | 3.94 | 4.73 |
AI Insights
Revenue Trend
Mar 2026 revenue at ₹407Cr, up 18.3% YoY. OPM at 35%.
Debt Position
Borrowings at ₹3Cr. Debt-to-equity ratio: 0.01x. Healthy balance sheet.
Capex Cycle
CWIP at ₹18Cr (6% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 0.13% (-2.01pp change). FIIs: 4.89% (+2.17pp change). Promoters hold 35.85%.
Margin & Efficiency
ROCE improving from 6% (Mar 2015) to 25% (Mar 2026). Working capital days: 84.
Valuation
PE 25.3x with 25.2% ROCE. Price is 337% above book value of ₹102. Dividend yield: 0.44%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 12 May - Investor Call Transcript- FY 2025-26- Q4 Earnings/ Investor Call held on 06th May 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication 7 May - Newspaper Publication of Audited Financial Results - Q4 FY 2025-26.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 6 May - Q4 FY2025-26 earnings call audio recording uploaded on company website.
- Announcement under Regulation 30 (LODR)-Change in Management 6 May - Dr. S. P. Vasireddi reappointed Executive Chairman for five years from 1 July 2026, subject to AGM approval.
- Corporate Action-Board approves Dividend 6 May - Board recommended ₹2 per share dividend for FY2025-26; record date 18 June 2026.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse